Sevoflurane — Class II drug recall D-1435-2019
Terminated recall by Baxter Healthcare Corporation, reported 2019-06-19, distributed nationwide. Failed Stability Specifications
| Recall number | D-1435-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Baxter Healthcare Corporation, Deerfield, IL, United States |
| Recall initiated | 2019-06-13 |
| Classified | 2019-06-28 |
| Reported by FDA | 2019-06-19 |
| Terminated | 2020-04-29 |
| Distributed | Nationwide (US) |
| Quantity | 5,940 bottles |
| Reason classes | specification failure |
| NDC | 10019-0651, 10019-0651-64, 10019-0655, 10019-0655-06 |
| Lot numbers | S110F822 |
| Expiration dates | 2021-05-31 |
Product
Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1435-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.